Application
TDRKH Antibody (N-term) western blot analysis in NCI-H460 cell line lysates (35ug/lane).This demonstrates the TDRKH antibody detected the TDRKH protein (arrow).Application
TDRKH antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human kidney tissue followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the TDRKH antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | TDRKH Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | TDRD2 |
|---|---|
| Alternative Names | TDRKH TDRD2 Tudor and KH domain-containing protein Tudor domain-containing protein 2 |
| Molecular Weight(MW) | 62046 Da |
| Tissue Specificity | This TDRKH antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 75-105 amino acids from the N-terminal region of human TDRKH. |
| Entrez Gene | 11022 |
|---|---|
| Nucleotide Accession | NP_006853.2 NP_001077432.1 NP_001077434.1 |
Application
TDRKH Antibody (N-term) western blot analysis in NCI-H460 cell line lysates (35ug/lane).This demonstrates the TDRKH antibody detected the TDRKH protein (arrow).
Application
TDRKH antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human kidney tissue followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the TDRKH antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
